Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abemaciclib and Letrozole in Endometrial Cancer
NCT04049227Phase 1Completed
- Sponsor
- Northwestern University
- Start
- Aug 2019
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of abemaciclib in endometrial endometrioid adenocarcinoma (EEA), sponsored by Northwestern University. Primary endpoint: Changes in Ki-67 expression at 6 weeks. Started Aug 2019; status: completed.
02
Drugs
abemaciclib
03
Conditions
endometrial endometrioid adenocarcinoma (EEA)
Beyond the preview
Go deeper on NCT04049227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04049227.